Clinical Trials
656 trialsProteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
National Institutes of Health Clinical Center (CC)
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
National Institutes of Health Clinical Center (CC)
REVEAL
Ono Pharmaceutical Co., Ltd.
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
Pediatric Vaccinations
NYU Langone Health
Study Protocol: Study on Incidence and Risk Factors of Mold Infections in Children During Leukemia Treatment
University of Southern Denmark
An Endotracheal Tube Inserted to the Level of the Hypopharynx
American University of Beirut Medical Center
SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
Rigshospitalet, Denmark
SEIFEM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
National Institutes of Health Clinical Center (CC)
realMIND
Incyte Corporation
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
H. Lee Moffitt Cancer Center and Research Institute
FRENCH-CYTO
Group for Research in Adult Acute Lymphoblastic Leukemia
IOL-VAC
Democritus University of Thrace
CVE-CART
Abramson Cancer Center at Penn Medicine
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
CS22-03
AIDS Malignancy Consortium
VIRAL
Children's Hospital of Philadelphia
Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development
Alexandria University
Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
Besponsa Post Marketing Surveillance Study
Pfizer
The Role of 18F-FDG-PET for Staging and Prognostication
Fondazione Italiana Linfomi - ETS
FIL_MOGA
Fondazione Italiana Linfomi - ETS
ANI-EP
University Hospital, Lille
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
University of Oregon
BESPONSA Injection 1 mg Special Investigation
Pfizer
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
AbbVie
INO-CD22
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Massachusetts General Hospital
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
AbbVie
HL-R2-B2
University Hospital, Bordeaux
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
Oncology Institute of Southern Switzerland
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
FIL_BIOWM
Fondazione Italiana Linfomi - ETS
SUMMIT
AstraZeneca
Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)
St. Jude Children's Research Hospital
Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults
SF Research Institute, Inc.
REBOUND
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Financial Difficulty in Patients With Blood Cancer
UNC Lineberger Comprehensive Cancer Center
Posture, Hand Functions and Sensory Processing Skills on Nutrition
Bezmialem Vakif University
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
CHARTHER
IRCCS San Raffaele
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
Karolinska Institutet
The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function
Kansas State University
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation
AstraZeneca
Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
Asan Medical Center
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Stanford University
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
BRIGHT-MBVD
Federico II University